BioSpace News Archive

Fact.MR, a market research and competitive intelligence provider: On medical device reprocessing, the global market is anticipated to top US$ 3 Bn by 2031, surging at a CAGR of 16% over the coming ten years.

The growing acceptance and demand for minimally invasive procedures are one of the prime factors driving the growth of the medical camera market.

RELIEF THERAPEUTICS Holding SA, a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, announced the appointment of Serene Forte, Ph.D., MPH, as Senior Vice President, Head of Genetic Medicine, effective July 18, 2022.

Evelo Biosciences, Inc., a clinical stage biotechnology company developing a novel platform of orally delivered medicines acting on the small intestinal axis, SINTAX, announced the appointment of Marella Thorell as Chief Financial Officer, effective September 1, 2022.

Tiziana Life Sciences Ltd. announces that it has appointed Matthew Davis, MD, RPh as its Chief Medical Officer and Acting Chief Scientific Officer, effective immediately.

ROME Therapeutics, a biotechnology company harnessing the power of the dark genome to develop breakthrough medicines for cancer and autoimmune diseases, announced the appointment of Jeff Hatfield as Chair of the ROME Board of Directors.

MAKO Medical Laboratories is purchasing four additional high-tech liquid handling automation systems after the initial successful evaluation of the first system for the company’s 70,000 square foot laboratory to allow the lab to more than double the COVID-19 testing capacity of a single lab technician in the future.

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its second quarter results on Wednesday, August 3, 2022, after the close of the market.

Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion ® to Improve Appearance of Lax (Loose) Skin.

Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize gene therapy with its commensal virome platform, today announced three upcoming presentations at the 41st Annual Meeting of the American Society for Virology to be held from July 16-20, 2022 in Madison, Wisconsin.